IDIQ contract for microbial identification (ID) and antibiotic susceptibility testing (AST) cards, base period: 1 OCT 2017 to 30 SEP 2018

Ended Indefinite Delivery Contract Awarded Last action

Contract number
W81K0217D0012
Awardee
Awarding agency
Task orders
5 $730,951 obligated

Award facts

Combined order value
$730,951 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 49% used
$1,501,969.18
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

This federal Indefinite Delivery Contract (IDC) was awarded by the U.S. Army Medical Command (MEDCOM) to Biomerieux Inc., a global leader in in vitro diagnostics. The contract, valued at up to $1,501,969.18, is for the supply of microbial identification (ID) and antibiotic susceptibility testing (AST) cards and reagents to support infectious disease testing and pathogen detection across government healthcare operations.

The contract includes multiple delivery orders issued from October 2017 through September 2022, with individual order ceiling values ranging from $80,185.02 to $213,300.68. These firm-fixed-price awards do not have any set-aside designations, as Biomerieux is often the sole-source provider for its proprietary diagnostic platforms, such as VITEK, BioFire, and VIDAS. The contracted products and services are delivered to locations in Eno Valley, North Carolina to support the MEDCOM's clinical laboratory and medical treatment facility requirements.

Task orders

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00007 $0
Exercise an Option P00006 · ID/AST cards/reagents. Exercise OPT 4: 1 OCT 2021 to 30 SEP 2022 $0
Supplemental Agreement for work within scope P00005 · 889 action option 3: 1 OCT 2020 to 30 SEP 2021 $0
Exercise an Option P00004 · D.O. For ID/AST cards/reagents for option 3 covering: 1 OCT 2020 to 30 SEP 2021 $0
Supplemental Agreement for work within scope P00003 $0
Exercise an Option P00002 · Biomerieux microbial identification (ID) and antibiotic susceptibility testing (AST) cards - exercise option 1 FR 1 OCT 20119 to 30 SEP 2020 $0
Exercise an Option P00001 · Exercise option 1 FR 1 OCT 2018 to 30 SEP 2019 for biomerieux microbial identification (ID) and antibiotic susceptibility testing (AST) cards $0
Original award $0

Quick answers

Who was awarded contract W81K0217D0012?

W81K0217D0012 was awarded to Biomerieux Inc. by Medical Command (Department of the Army) on October 1, 2017.

How much is contract W81K0217D0012 worth?

Orders under W81K0217D0012 have obligated $730,951. W81K0217D0012's own ceiling is $1,501,969.

How many orders have been placed under contract W81K0217D0012?

5 orders have been placed under W81K0217D0012, the latest on October 1, 2021.

Who can order from contract W81K0217D0012?

W81K0217D0012 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract W81K0217D0012 competed?

The extent of competition for W81K0217D0012 was not competed under sap. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV